(Health Korea News / Changyong Lee) ‘Pharmaceutical 24 Hours’ is a corner that shows brief news related to pharmaceutical and biotechnology at a glance that is easy to miss. It may seem like trivial news, but it could be valuable information to someone, so we summarize the facts and present them in an easy-to-understand manner.
◆ Obtained an integrated grade of ‘A’, up 2 levels in Celltrion’s ESG evaluation, etc.
Celltrion announced on the 13th that it recently obtained an ‘integrated grade of A’ in the ESG (Environmental, Social, Governance) evaluation from the Korea ESG Standards Service (KCGS).
KCGS is a non-profit corporation established to support sustainable growth of companies and contribute to the capital market. Every year, we evaluate companies and announce ratings with a focus on the environment, social responsibility, and sound and transparent governance. This year, the evaluation was conducted on 794 companies listed on the stock market.
Celltrion earned an A grade in the environment and governance sector and an A+ grade in the social sector, respectively, and was selected as an integrated grade ‘A’, proving its excellent performance in overall ESG management. According to KCGS, Grade A is a grade recognized as having an appropriate sustainable management system in terms of environment, society, and governance, and with little risk of damage to shareholder value due to non-financial risks. This rating is evaluated as a key indicator that refers to the overall level of a company’s ESG management, and the Korea Exchange also uses it to construct the KRX ESG Investment Index stocks.
Celltrion is pursuing ESG management to become a ‘global comprehensive biotechnology company that realizes the value of promoting human health and welfare’ with the vision of ‘building a sustainable medical service ecosystem based on ESG management’. To this end, we are strengthening activities in each field by establishing systematic ESG governance, such as establishing a dedicated ESG department under the CEO in 2022 and forming an ESG committee under the Board of Directors.
◆ Hugel successfully holds HA filler seminar for French medical staff
Hugel announced on the 13th that it recently held the ‘HELF Global Expert Workshop’ for medical staff in the French cosmetic surgery field and conducted a seminar on safe and effective HA filler treatment.
HELF (Hugel Expert Leader’s Forum) is Hugel’s representative global academic forum that has been held since 2013. Starting this year, we have been inviting overseas medical experts through the detailed program Global Expert Workshop to deliver the latest insights, trends, and surgical know-how in the field of cosmetic surgery.
This event consisted of a theoretical lecture and live demo on the topic of improving full face volume, with about 10 French medical staff in attendance.
Director Choi Han-mo of Bymi Plastic Surgery Clinic, who participated as a speaker, introduced the mechanism and scope of application of HA filler, whose main ingredient is hyaluronic acid, and then used Hugel’s HA filler ‘The Chaeum (export name: Revolax)’ to create a natural look. A procedure that gives balance to the entire face through volume was introduced.
When treating HA fillers in multiple areas, medical staff in Europe, including France, generally perform treatments at intervals of two weeks or more, and patients may visit the hospital for up to several months.
Hugel said, “Director Choi carefully considered the patient’s condition and aesthetics and performed a skilled procedure that was completed within a day using the right amount of filler, so the French medical staff showed a high level of satisfaction with the event.”
◆ Dongsung Pharmaceutical-New Risen, eco-friendly cleantech MOU signed
Dongseong Pharmaceutical signed a business agreement with Newrizon, a next-generation new material company, to strengthen cooperation in the cleantech business.
The business agreement promotes marketing support and cooperation in related categories, including eco-friendly projects conducted by both companies, and contains contents for sustainable development.
Dongsung Pharmaceutical plans to strengthen its competitiveness in the domestic cleantech market by using the next-generation nano-fusion Durafiltex material developed and patented by New Risen. We plan to provide the market with a variety of environmental solutions that combine the technologies of both companies.
Na Won-gyun, CEO of Dongsung Pharmaceutical, said, “We will maximize synergy by applying New Risen’s new material cleantech technology to Dongsung’s A-ZERO, an air sterilizer specializing in cooking fumes.”
Meanwhile, Dongseong A-ZERO recently announced the effect of improving air quality in collaboration with Kyung Hee University’s Department of Environmental Engineering and Air Particle Treatment Laboratory, publicizing the excellence of the device.
◆ Mertz Aesthetics Korea successfully held the ‘MEX Symposium’ to share the latest knowledge with medical staff
Mertz Aesthetics Korea (Mults) held the ‘MEX Symposium’ with the theme ‘Touch of Professional’ at the Paradise Hotel in Incheon on October 26th. This symposium was prepared to convey respect to medical professionals leading the domestic aesthetic industry.
This symposium was attended by Dr. Luiz Perez, CEO of Espaço Mira Clinic in Sao Paulo, Brazil, as well as Apgujeong Oracle Dermatology Clinic Director Park Je-young and Day One Clinic Director Kim Jung-soo. At the symposium, experts’ knowledge was actively shared on treatment methods tailored to individual patients, various medical aesthetic treatment cases, and the safety of the company’s brand portfolio.
The first speaker, Dr. Perez, introduced various treatment cases of RADIESSE® in actual clinical settings in Brazil and shared results on efficacy and safety with RADIESSE® through long-term treatment outcome data.
Director Jeyoung Park, who was the speaker for the second session, presented various cases of using Radiesse in Korea under the topic of ‘Advanced Solutions for Asian with Radiesse.’
◆ National Health Insurance Corporation, selected as an excellent institution for the 8th consecutive time in the ‘2024 Comprehensive Records Management Evaluation’
On the 12th, the National Health Insurance Corporation announced that it had been selected as an excellent institution for the 8th consecutive time since 2012 by obtaining a ‘Grade A’ in the ‘2024 (2023 Performance) Comprehensive Record Management Evaluation’ hosted by the Ministry of Public Administration and Security.
Records management evaluation has been conducted every year since 2007 to strengthen and improve the records management capabilities of public institutions. This year, 38 public institutions under the government and city and provincial offices of education were evaluated.
An official from the Corporation said, “In this evaluation, we received a ‘Gap grade (90 points)’ in a total of three areas, including records management work base, records management work promotion, and others, once again being recognized for our capabilities as a transparent and systematic records management agency. “He said.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
